JP2025029049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025029049A5 JP2025029049A5 JP2024209192A JP2024209192A JP2025029049A5 JP 2025029049 A5 JP2025029049 A5 JP 2025029049A5 JP 2024209192 A JP2024209192 A JP 2024209192A JP 2024209192 A JP2024209192 A JP 2024209192A JP 2025029049 A5 JP2025029049 A5 JP 2025029049A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- nucleic acid
- acid molecule
- naturally occurring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962877577P | 2019-07-23 | 2019-07-23 | |
| US201962877551P | 2019-07-23 | 2019-07-23 | |
| US201962877561P | 2019-07-23 | 2019-07-23 | |
| US201962877508P | 2019-07-23 | 2019-07-23 | |
| US201962877532P | 2019-07-23 | 2019-07-23 | |
| US201962877516P | 2019-07-23 | 2019-07-23 | |
| US201962877540P | 2019-07-23 | 2019-07-23 | |
| US201962877524P | 2019-07-23 | 2019-07-23 | |
| US62/877,516 | 2019-07-23 | ||
| US62/877,551 | 2019-07-23 | ||
| US62/877,540 | 2019-07-23 | ||
| US62/877,508 | 2019-07-23 | ||
| US62/877,577 | 2019-07-23 | ||
| US62/877,524 | 2019-07-23 | ||
| US62/877,561 | 2019-07-23 | ||
| US62/877,532 | 2019-07-23 | ||
| PCT/US2020/042854 WO2021016227A1 (en) | 2019-07-23 | 2020-07-21 | Synthetic genetic elements for biomanufacture |
| JP2022503956A JP7598920B2 (ja) | 2019-07-23 | 2020-07-21 | 生物製造のための合成遺伝子要素 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022503956A Division JP7598920B2 (ja) | 2019-07-23 | 2020-07-21 | 生物製造のための合成遺伝子要素 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025029049A JP2025029049A (ja) | 2025-03-05 |
| JP2025029049A5 true JP2025029049A5 (enExample) | 2025-07-01 |
Family
ID=72039670
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022503956A Active JP7598920B2 (ja) | 2019-07-23 | 2020-07-21 | 生物製造のための合成遺伝子要素 |
| JP2024209192A Pending JP2025029049A (ja) | 2019-07-23 | 2024-12-02 | 生物製造のための合成遺伝子要素 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022503956A Active JP7598920B2 (ja) | 2019-07-23 | 2020-07-21 | 生物製造のための合成遺伝子要素 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12049638B2 (enExample) |
| EP (1) | EP4003430A1 (enExample) |
| JP (2) | JP7598920B2 (enExample) |
| CN (2) | CN114514319B (enExample) |
| AU (1) | AU2020316034A1 (enExample) |
| CA (1) | CA3148079A1 (enExample) |
| IL (1) | IL289968A (enExample) |
| TW (1) | TW202116794A (enExample) |
| WO (1) | WO2021016227A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023536148A (ja) | 2020-07-30 | 2023-08-23 | シェイプ セラピューティクス インク． | Ｒａａｖウイルス粒子の誘導産生のための安定な細胞株 |
| WO2023147511A2 (en) * | 2022-01-28 | 2023-08-03 | Shape Therapeutics Inc. | Systems for amplification of aav rep and cap proteins |
| JP2025512585A (ja) * | 2022-04-25 | 2025-04-17 | ヤンセン・リサーチ・アンド・ディベロップメント・エルエルシー | アデノ随伴ウイルスパッケージングベクター及びそれを使用する方法 |
| WO2025054007A1 (en) * | 2023-09-06 | 2025-03-13 | Shape Therapeutics Inc. | Genetic elements to increase recombinant aav production |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7348178B1 (en) * | 1994-03-14 | 2008-03-25 | New York University Medical Center | Recombinant adenoviral vector system |
| US6413776B1 (en) | 1998-06-12 | 2002-07-02 | Galapagos Geonomics N.V. | High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| US20030190746A1 (en) | 2002-04-04 | 2003-10-09 | Xiao Xiao | Gene expression control system and its use in recombinant virus packaging cell lines |
| US9034650B2 (en) | 2005-02-02 | 2015-05-19 | Intrexon Corporation | Site-specific serine recombinases and methods of their use |
| DK2061891T3 (da) | 2006-08-24 | 2012-07-23 | Virovek Inc | Ekspression i insektceller af gener med overlappende åbne læserammer, fremgangsmåder og sammensætninger hertil |
| GB201609597D0 (en) * | 2016-06-01 | 2016-07-13 | Univ Sheffield | Therapy |
| GB201703416D0 (en) | 2017-03-03 | 2017-04-19 | Ge Healthcare Bio Sciences Ab | Method for protein expression |
| GB201706090D0 (en) * | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Methods for adeno-associated viral vector production |
-
2020
- 2020-07-21 US US16/934,970 patent/US12049638B2/en active Active
- 2020-07-21 WO PCT/US2020/042854 patent/WO2021016227A1/en not_active Ceased
- 2020-07-21 AU AU2020316034A patent/AU2020316034A1/en active Pending
- 2020-07-21 JP JP2022503956A patent/JP7598920B2/ja active Active
- 2020-07-21 CA CA3148079A patent/CA3148079A1/en active Pending
- 2020-07-21 EP EP20754081.6A patent/EP4003430A1/en active Pending
- 2020-07-21 TW TW109124636A patent/TW202116794A/zh unknown
- 2020-07-21 CN CN202080065603.3A patent/CN114514319B/zh active Active
- 2020-07-21 CN CN202510766180.2A patent/CN120700001A/zh active Pending
-
2022
- 2022-01-19 IL IL289968A patent/IL289968A/en unknown
-
2024
- 2024-06-14 US US18/744,565 patent/US20240327869A1/en active Pending
- 2024-12-02 JP JP2024209192A patent/JP2025029049A/ja active Pending